Keywords: Pfizer, M&A, Teuto Brasileiro, Brazil, Generics market

Another foray into generics by Pfizer as it buys 40% stake in Brazil’s Teuto for $240 million upfront

Article | 21 October 2010

Print This

Hot on the heels of its $350 million deal for insulin biosimilars with India’s Biocon (The Pharma Letter October 19), ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in